Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT06347120
Eligibility Criteria:
Inclusion Criteria:
* Presence of an obstruction believed to be secondary to adhesions (abdominal pain and distention, nausea and/or vomiting, no gas and/or stool).
* Uncomplicated presentation (no signs of strangulation or peritonitis).
* IV CT scan of the abdomen consistent with an uncomplicated ASBO, (performed with a pillow to raise slightly the patient.
* Aged 18 or older.
* Provision of written, informed consent.
* Patient covered by French national health insurance.
Exclusion Criteria:
* An incarcerated and/or strangulated incisional hernia, colonic obstruction.
* No previous abdominal operation.
* Obstruction within 4 weeks after a recent operation.
* Gastrointestinal neoplasm in progress.
* Inflammatory bowel disease in progress.
* Abdominal radiotherapy in the last 6 months.
* Contraindication to intravenous contrast enhancement for the CT scan, pre-existing risks factors for pneumonitis.
* Antecedent of aspiration pneumonia.
* Age \> 85 years.
* Orientation disturbance.
* Bedridden.
* Chronic cerebrovascular disease (cerebral infarction sequelae, Parkinson disease etc).
* Dementia.
* Gastroesophageal disorder (gastroesophageal reflux)
* Pregnancy or breastfeeding.
* Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision).
* Patients unable to provide informed consent.
* Age \<18 years.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT06347120
Study Brief:
Protocol Section:
NCT06347120